EIF4G2 and hepatocellular carcinoma: As shown in Table 1, EIF4G2 overexpression was significantly related to cases with a higher T stage (T2/T3, p = 0.01), a higher TNM stage (II/III, p = 0.01), HCC recurrence (p = 0.044) and PDL1 positive expression (p = 0.035).